Polygenic risk scores in psychiatry: Will they be useful for clinicians?
paper
Cited
Public
- Authors
- Fullerton, Janice M; Nurnberger, John I
- Year
- 2019
- Journal
- F1000Research
- PMID
- 31448085
- DOI
- 10.12688/f1000research.18491.1
- PMCID
- PMC6676506
Major psychiatric disorders are heritable but they are genetically complex. This means that, with certain exceptions, single gene markers will not be helpful for diagnosis. However, we are learning more about the large number of gene variants that, in combination, are associated with risk for disorders such as schizophrenia, bipolar disorder, and other psychiatric conditions. The presence of those risk variants may now be combined into a polygenic risk score (PRS). Such a score provides a quantitative index of the genomic burden of risk variants in an individual, which relates to the likelihood that a person has a particular disorder. Currently, such scores are quite useful in research, and they are telling us much about the relationships between different disorders and other indices of brain function. In the future, as the datasets supporting the development of such scores become larger and more diverse and as methodological developments improve predictive capacity, we expect that PRS will have substantial clinical utility in the assessment of risk for disease, subtypes of disease, and even treatment response. Here, we provide an overview of PRS in general terms (including a glossary suitable for informed non-geneticists) and discuss the use of PRS in psychiatry, including their limitations and cautions for interpretation, as well as their applications now and in the future.
An example of the population distributions of polygenic risk scores (PRS).The black lines represent the distribution of PRS for a complex genetic condition in the (top) general population and (bottom) a case population of individuals affected with the condition. At a population level, the average PRS in the case group is higher than the average PRS in the control group, although many cases will have lower scores than the average person from the general population. The red line indicates a single individual with a “high PRS” – this individual has a score which lies in the top 94% in the general population and the top 90% in case population.
Potential clinical uses of polygenic risk scores.BP, bipolar disorder; BP1, bipolar disorder - type 1, BP2, bipolar disorder - type 2, ECT, electroconvulsive therapy; MDD, major depressive disorder; SA, schizoaffective disorder; SZ, schizophrenia.
1–20 of 46
Next →
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
| Citation | PMID | DOI | Status |
|---|---|---|---|
| AllardyceJLeonenkoGHamshereM: Association Between Schizophrenia-Related Polygenic Liability and the Occurrence and Level of Mood-Incongruent Psychotic Symptoms in Bipolar Disorder. JAMA Psychiatry. 2018;75(1):28–35. 10.1001/jamapsychiatry.2017.3485 29167880PMC5833541 | — | — | — |
| AmareATSchubertKOHouL: Association of Polygenic Score for Schizophrenia and HLA Antigen and Inflammation Genes With Response to Lithium in Bipolar Affective Disorder: A Genome-Wide Association Study. JAMA Psychiatry. 2018;75(1):65–74. 10.1001/jamapsychiatry.2017.3433 29121268PMC5833535 | — | — | — |
| AustinJSemakaAHadjipavlouG: Conceptualizing genetic counseling as psychotherapy in the era of genomic medicine. J Genet Couns. 2014;23(6):903–9. 10.1007/s10897-014-9728-1 24841456PMC4318692 | — | — | — |
| BigdeliTBRipkeSBacanuSA: Genome-wide association study reveals greater polygenic loading for schizophrenia in cases with a family history of illness. Am J Med Genet B Neuropsychiatr Genet. 2016;171B(2):276–89. 10.1002/ajmg.b.32402 26663532PMC5816590 | — | — | — |
| CalafatoMSThygesenJHRanlundS: Use of schizophrenia and bipolar disorder polygenic risk scores to identify psychotic disorders. Br J Psychiatry. 2018;213(3):535–41. 10.1192/bjp.2018.89 30113282PMC6130805 | — | — | — |
| CostelloEJMustilloSErkanliA: Prevalence and development of psychiatric disorders in childhood and adolescence. Arch Gen Psychiatry. 2003;60(8):837–44. 10.1001/archpsyc.60.8.837 12912767 | — | — | — |
| Cross-Disorder Group of the Psychiatric Genomics Consortium, LeeSHRipkeS: Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet. 2013;45(9):984–94. 10.1038/ng.2711 23933821PMC3800159 | — | — | — |
| CurtisD: Polygenic risk score for schizophrenia is more strongly associated with ancestry than with schizophrenia. Psychiatr Genet. 2018;28(5):85–89. 10.1097/YPG.0000000000000206 30160659 | — | — | — |
| DudbridgeF: Polygenic Epidemiology. Genet Epidemiol. 2016;40(4):268–72. 10.1002/gepi.21966 27061411PMC4982028 | — | — | — |
| FisherRA: XV.—The Correlation between Relatives on the Supposition of Mendelian Inheritance. Trans R Soc Edinb. 1919;52:399–433. 10.1017/S0080456800012163 | — | — | — |
| FrazerKABallingerDGCoxDR: A second generation human haplotype map of over 3.1 million SNPs. Nature. 2007;449(7164):851–61. 10.1038/nature06258 17943122PMC2689609 | — | — | — |
| FullertonJMKollerDLEdenbergHJ: Assessment of first and second degree relatives of individuals with bipolar disorder shows increased genetic risk scores in both affected relatives and young At-Risk Individuals. Am J Med Genet B Neuropsychiatr Genet. 2015;168(7):617–29. 10.1002/ajmg.b.32344 26178159PMC5054905 | — | — | — |
| GeTChenCYNiY: Polygenic prediction via Bayesian regression and continuous shrinkage priors. Nat Commun. 2019;10(1): 1776. 10.1038/s41467-019-09718-5 30992449PMC6467998 | — | — | — |
| GibsonG: Going to the negative: genomics for optimized medical prescription. Nat Rev Genet. 2019;20(1):1–2. 10.1038/s41576-018-0061-7 30348998 | — | — | — |
| GlahnDCNimgaonkarVLRaventósH: Rediscovering the value of families for psychiatric genetics research. Mol Psychiatry. 2019;24(4):523–35. 10.1038/s41380-018-0073-x 29955165PMC7028329 | — | — | — |
| GroveJRipkeSAlsTD: Identification of common genetic risk variants for autism spectrum disorder. Nat Genet. 2019;51(3):431–44. 10.1038/s41588-019-0344-8 30804558PMC6454898 | — | — | — |
| HamshereMLO'DonovanMCJonesIR: Polygenic dissection of the bipolar phenotype. Br J Psychiatry. 2011;198(4):284–8. 10.1192/bjp.bp.110.087866 21972277PMC3065773 | — | — | — |
| Hari DassSAMcCrackenKPokhvisnevaI: A biologically-informed polygenic score identifies endophenotypes and clinical conditions associated with the insulin receptor function on specific brain regions. EBioMedicine. 2019;42:188–202. 10.1016/j.ebiom.2019.03.051 30922963PMC6491717 | — | — | — |
| HoDSWSchierdingWWakeM: Machine Learning SNP Based Prediction for Precision Medicine. Front Genet. 2019;10:10. 10.3389/fgene.2019.00267 30972108PMC6445847 | — | — | — |
| HowardDMAdamsMJClarkeTK: Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions. Nat Neurosci. 2019;22(3):343–352. 10.1038/s41593-018-0326-7 30718901PMC6522363 | — | — | — |
| HuangHChengSDingM: Integrative analysis of transcriptome-wide association study and mRNA expression profiles identifies candidate genes associated with autism spectrum disorders. Autism Res. 2019;12(1):33–8. 10.1002/aur.2048 30561910 | — | — | — |
| HuangLJakobssonMPembertonTJ: Haplotype variation and genotype imputation in African populations. Genet Epidemiol. 2011;35(8):766–80. 10.1002/gepi.20626 22125220PMC3568705 | — | — | — |
| International Schizophrenia Consortium, PurcellSMWrayNR: Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature. 2009;460(7256):748–52. 10.1038/nature08185 19571811PMC3912837 | — | — | — |
| KheraAVChaffinMAragamKG: Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nat Genet. 2018;50(9):1219–24. 10.1038/s41588-018-0183-z 30104762PMC6128408 | — | — | — |
| KheraAVChaffinMWadeKH: Polygenic Prediction of Weight and Obesity Trajectories from Birth to Adulthood. Cell. 2019;177(3):587–596.e9. 10.1016/j.cell.2019.03.028 31002795PMC6661115 | — | — | — |
| MakTSHPorschRMChoiSW: Polygenic scores via penalized regression on summary statistics. Genet Epidemiol. 2017;41(6):469–80. 10.1002/gepi.22050 28480976 | — | — | — |
| MalhotraDSebatJ: CNVs: Harbingers of a rare variant revolution in psychiatric genetics. Cell. 2012;148(6):1223–41. 10.1016/j.cell.2012.02.039 22424231PMC3351385 | — | — | — |
| MartinARKanaiMKamataniY: Clinical use of current polygenic risk scores may exacerbate health disparities. Nat Genet. 2019;51(4):584–91. 10.1038/s41588-019-0379-x 30926966PMC6563838 | — | — | — |
| MavaddatNMichailidouKDennisJ: Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes. Am J Hum Genet. 2019;104(1):21–34. 10.1016/j.ajhg.2018.11.002 30554720PMC6323553 | — | — | — |
| MullinsNBigdeliTBBørglumAD: Genome-wide association study of suicide attempt in psychiatric disordersidentifies association with major depression polygenic risk scores. Am J Psychiatry.(in press). Reference Source 10.1176/appi.ajp.2019.18080957PMC667565931164008 | — | — | — |
| MuranenTAMavaddatNKhanS: Polygenic risk score is associated with increased disease risk in 52 Finnish breast cancer families. Breast Cancer Res Treat. 2016;158(3):463–9. 10.1007/s10549-016-3897-6 27438779PMC4963452 | — | — | — |
| MuslinerKLMortensenPBMcGrathJJ: Association of Polygenic Liabilities for Major Depression, Bipolar Disorder, and Schizophrenia With Risk for Depression in the Danish Population. JAMA Psychiatry. 2019;76(5):516–25. 10.1001/jamapsychiatry.2018.4166 30698613PMC6495355 | — | — | — |
| Márquez-LunaCLohPRPriceAL: Multiethnic polygenic risk scores improve risk prediction in diverse populations. Genet Epidemiol. 2017;41(8):811–823. 10.1002/gepi.22083 29110330PMC5726434 | — | — | — |
| NurnbergerJIAustinJBerrettiniWH: What Should a Psychiatrist Know About Genetics? Review and Recommendations From the Residency Education Committee of the International Society of Psychiatric Genetics. J Clin Psychiatry. 2018;80(1): pii: 17nr12046. 10.4088/JCP.17nr12046 30549495PMC6480395 | — | — | — |
| PardiñasAFHolmansPPocklingtonAJ: Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection. Nat Genet. 2018;50(3):381–389. 10.1038/s41588-018-0059-2 29483656PMC5918692 | — | — | — |
| PintoDPagnamentaATKleiL: Functional impact of global rare copy number variation in autism spectrum disorders. Nature. 2010;466(7304):368–72. 10.1038/nature09146 20531469PMC3021798 | — | — | — |
| PulayAJRéthelyiJM: Multimarker analysis suggests the involvement of BDNF signaling and microRNA biosynthesis in suicidal behavior. Am J Med Genet B Neuropsychiatr Genet. 2016;171(6):763–76. 10.1002/ajmg.b.32433 26921221 | — | — | — |
| RampinoATaurisanoPFanelliG: A Polygenic Risk Score of glutamatergic SNPs associated with schizophrenia predicts attentional behavior and related brain activity in healthy humans. Eur Neuropsychopharmacol. 2017;27(9):928–939. 10.1016/j.euroneuro.2017.06.005 28651857 | — | — | — |
| RanlundSCalafatoSThygesenJH: A polygenic risk score analysis of psychosis endophenotypes across brain functional, structural, and cognitive domains. Am J Med Genet B Neuropsychiatr Genet. 2018;177(1):21–34. 10.1002/ajmg.b.32581 28851104PMC5763362 | — | — | — |
| ReichDECargillMBolkS: Linkage disequilibrium in the human genome. Nature. 2001;411(6834):199–204. 10.1038/35075590 11346797 | — | — | — |
| RuderferDMRipkeSMcQuillinA: Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes. Cell. 2018;173(7):1705–1715.e16. 10.1016/j.cell.2018.05.046 29906448PMC6432650 | — | — | — |
| RutterMSroufeLA: Developmental psychopathology: concepts and challenges. Dev Psychopathol. 2000;12(3):265–96. 10.1017/S0954579400003023 11014739 | — | — | — |
| Schizophrenia Working Group of the Psychiatric Genomics Consortium: Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511(7510):421–7. 10.1038/nature13595 25056061PMC4112379 | — | — | — |
| SoHCShamPC: Exploring the predictive power of polygenic scores derived from genome-wide association studies: A study of 10 complex traits. Bioinformatics. 2017;33(6):886–892. 10.1093/bioinformatics/btw745 28065900 | — | — | — |
| SullivanPF: The psychiatric GWAS consortium: big science comes to psychiatry. Neuron. 2010;68(2):182–6. 10.1016/j.neuron.2010.10.003 20955924PMC2991765 | — | — | — |
| VassosEDi FortiMColemanJ: An Examination of Polygenic Score Risk Prediction in Individuals With First-Episode Psychosis. Biol Psychiatry. 2017;81(6):470–477. 10.1016/j.biopsych.2016.06.028 27765268 | — | — | — |
| VilhjálmssonBJYangJFinucaneHK: Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores. Am J Hum Genet. 2015;97(4):576–92. 10.1016/j.ajhg.2015.09.001 26430803PMC4596916 | — | — | — |
| WaltersRKPolimantiRJohnsonEC: Transancestral GWAS of alcohol dependence reveals common genetic underpinnings with psychiatric disorders. Nat Neurosci. 2018;21(12):1656–69. 10.1038/s41593-018-0275-1 30482948PMC6430207 | — | — | — |
| WangDLiuSWarrellJ: Comprehensive functional genomic resource and integrative model for the human brain. Science. 2018;362(6420): pii: eaat8464. 10.1126/science.aat8464 30545857PMC6413328 | — | — | — |
| WardJGrahamNStrawbridgeRJ: Polygenic risk scores for major depressive disorder and neuroticism as predictors of antidepressant response: Meta-analysis of three treatment cohorts. PLoS One. 2018;13(9):e0203896. 10.1371/journal.pone.0203896 30240446PMC6150505 | — | — | — |
| Wassertheil-SmollerSQiQDaveT: Polygenic Risk for Depression Increases Risk of Ischemic Stroke: From the Stroke Genetics Network Study. Stroke. 2018;49(3):543–548. 10.1161/STROKEAHA.117.018857 29438084PMC5909718 | — | — | — |
| WrayNRGoddardMEVisscherPM: Prediction of individual genetic risk to disease from genome-wide association studies. Genome Res. 2007;17(10):1520–8. 10.1101/gr.6665407 17785532PMC1987352 | — | — | — |
| YuTWChahrourMHCoulterME: Using whole-exome sequencing to identify inherited causes of autism. Neuron. 2013;77(2):259–73. 10.1016/j.neuron.2012.11.002 23352163PMC3694430 | — | — | — |
| ZhangJPRobinsonDYuJ: Schizophrenia Polygenic Risk Score as a Predictor of Antipsychotic Efficacy in First-Episode Psychosis. Am J Psychiatry. 2019;176(1):21–28. 10.1176/appi.ajp.2018.17121363 30392411PMC6461047 | — | — | — |
| ZheutlinABChekroudAMPolimantiR: Multivariate Pattern Analysis of Genotype-Phenotype Relationships in Schizophrenia. Schizophr Bull. 2018;44(5):1045–1052. 10.1093/schbul/sby005 29534239PMC6101611 | — | — | — |
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| High Polygenic Risk Scores Are Associated With Early Age of Onset of Alcohol Use Disorder in Adolescents and Young Adults at Risk. | 2022 | 36324664 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Patient Perspectives on Psychiatric Polygenic Risk Scores in Reproductive Decision-Making and Polygenic Embryo Screening. | Ginn LA et al. | — | 2026 | → |
| Polygenic contributions to brain cortical measures, subcortical volumes and hippocampal subfields in first episode psychosis. | Segura AG et al. | — | 2026 | → |
| The Future of <i>DSM</i>: Role of Candidate Biomarkers and Biological Factors. | Cuthbert B et al. | — | 2026 | → |
| Viewing direct-to-consumer genetic test results for depression risk is psychologically well tolerated: Evidence from a longitudinal equivalence study. | Berns RMK et al. | — | 2026 | → |
| Integrated Transcriptome Analysis Reveals Novel Molecular Signatures for Schizophrenia Characterization. | Ni T et al. | — | 2025 | → |
| Low Stability and Specificity of Polygenic Risk Scores for Major Psychiatric Disorders Limit Their Clinical Utility. | Mollon J et al. | — | 2025 | → |
| Person-level contributions of bipolar polygenic risk score to the prediction of new-onset bipolar disorder in at-risk offspring. | Hafeman DM et al. | — | 2025 | → |
| Clinical and genetic contributions to medical comorbidity in bipolar disorder: a study using electronic health records-linked biobank data. | Sanchez-Ruiz JA et al. | — | 2024 | → |
| [Genetic Diagnostics in Everyday Clinical Practice in Child and Adolescent Psychiatry: Indications, Framework Conditions, Hurdles, and Proposed Solutions]. | Degenhardt F et al. | — | 2024 | → |
| Identification of women at high risk of postpartum psychiatric episodes: A population-based study quantifying relative and absolute risks following exposure to selected risk factors and genetic liability. | Johannsen BMW et al. | — | 2024 | → |
| The ethics of polygenic scores in psychiatry: minefield or opportunity for patient-centered psychiatry? | Wouters RHP et al. | — | 2024 | → |
| Clinical utility of polygenic risk scores: a critical 2023 appraisal. | Koch S et al. | — | 2023 | → |
| Cognitive performances across individuals at high genetic risk for schizophrenia, high genetic risk for bipolar disorder, and low genetic risks: a combined polygenic risk score approach. | Ohi K et al. | — | 2023 | → |
| Current State of Modeling Human Psychiatric Disorders Using Zebrafish. | Costa FV et al. | — | 2023 | → |
| Emerging trends in gene and bipolar disorder research: a bibliometric analysis and network visualisation. | Zakaria WNA et al. | — | 2023 | → |
| Epigenetics applied to child and adolescent mental health: Progress, challenges and opportunities. | Cecil CAM et al. | — | 2023 | → |
| Ethical, legal, and social implications of genetic risk prediction for multifactorial disease: a narrative review identifying concerns about interpretation and use of polygenic scores. | Chapman CR | — | 2023 | → |
| Family environment and polygenic risk in the bipolar high-risk context. | Stapp EK et al. | — | 2023 | → |
| Genetics and epigenetics of stress: New avenues for an old concept. | Soliva-Estruch M et al. | — | 2023 | → |
| Identifying genetic loci and phenomic associations of substance use traits: A multi-trait analysis of GWAS (MTAG) study. | Xu H et al. | — | 2023 | → |
| Maternal prenatal depression is associated with dysregulation over the first five years of life moderated by child polygenic risk for comorbid psychiatric problems. | Babineau V et al. | — | 2023 | → |
| Psychiatric polygenic risk as a predictor of COVID-19 risk and severity: insight into the genetic overlap between schizophrenia and COVID-19. | Alemany-Navarro M et al. | — | 2023 | → |
| Research progress and challenges of preimplantation genetic testing for polygenic diseases. | Wu X et al. | — | 2023 | → |
| A genetically informed prediction model for suicidal and aggressive behaviour in teens. | Tate AE et al. | — | 2022 | → |
| Association Between Polygenic Risk Scores and Outcome of ECT. | Sigström R et al. | — | 2022 | → |
| Barriers to genetic testing in clinical psychiatry and ways to overcome them: from clinicians' attitudes to sociocultural differences between patients across the globe. | Pinzón-Espinosa J et al. | — | 2022 | → |
| Cognition in older adults with bipolar disorder: An ISBD task force systematic review and meta-analysis based on a comprehensive neuropsychological assessment. | Montejo L et al. | — | 2022 | → |
| Dissecting the genetic architecture of suicide attempt and repeated attempts in Korean patients with bipolar disorder using polygenic risk scores. | Lee D et al. | — | 2022 | → |
| Epigenetic signatures relating to disease-associated genotypic burden in familial risk of bipolar disorder. | Hesam-Shariati S et al. | — | 2022 | → |
| Gene-drug pairings for antidepressants and antipsychotics: level of evidence and clinical application. | Murphy LE et al. | — | 2022 | → |
| High Polygenic Risk Scores Are Associated With Early Age of Onset of Alcohol Use Disorder in Adolescents and Young Adults at Risk. | Nurnberger JI et al. | — | 2022 | → |
| Implementation of individualised polygenic risk score analysis: a test case of a family of four. | Corpas M et al. | — | 2022 | → |
| Major Depressive Disorder: Existing Hypotheses about Pathophysiological Mechanisms and New Genetic Findings. | Kamran M et al. | — | 2022 | → |
| Multi-trait Analysis of GWAS (MTAG) of Substance Use Traits Identifies Novel Genetic Loci and Phenomic Associations | Xu H et al. | — | 2022 | — |
| Polygenic risk for schizophrenia as a moderator of associations between childhood trauma and schizotypy. | Tonini E et al. | — | 2022 | → |
| Risk of non-fatal suicide attempt in individuals with substance use disorder: the roles of aggregate genetic liability and environmental exposures in a Swedish population-based cohort. | Lannoy S et al. | — | 2022 | → |
| Role of Polygenic Risk Score in the Familial Transmission of Bipolar Disorder in Youth. | Birmaher B et al. | — | 2022 | → |
| The Promise and Peril of Genetics. | Dick DM | — | 2022 | → |
| Transmembrane protein 108 inhibits the proliferation and myelination of oligodendrocyte lineage cells in the corpus callosum. | Wu Y et al. | — | 2022 | → |
| Analysis of genetic differences between psychiatric disorders: exploring pathways and cell types/tissues involved and ability to differentiate the disorders by polygenic scores. | Rao S et al. | — | 2021 | → |
| Contributions of PTSD polygenic risk and environmental stress to suicidality in preadolescents. | Daskalakis NP et al. | — | 2021 | → |
| Ethical concerns relating to genetic risk scores for suicide. | Docherty A et al. | — | 2021 | → |
| Genetic Basis of Dual Diagnosis: A Review of Genome-Wide Association Studies (GWAS) Focusing on Patients with Mood or Anxiety Disorders and Co-Occurring Alcohol-Use Disorders. | Stoychev K et al. | — | 2021 | → |
| Genetics of obsessive-compulsive disorder. | Mahjani B et al. | — | 2021 | → |
| Integration of evidence across human and model organism studies: A meeting report. | Palmer RHC et al. | — | 2021 | → |
| Pleiotropy between language impairment and broader behavioral disorders-an investigation of both common and rare genetic variants. | Nudel R et al. | — | 2021 | → |
| Shared sets of correlated polygenic risk scores and voxel-wise grey matter across multiple traits identified via bi-clustering. | Rahaman MA et al. | — | 2021 | → |
| Signature-based approaches for informed drug repurposing: targeting CNS disorders. | Shukla R et al. | — | 2021 | → |
| Systematic Review of Functional MRI Applications for Psychiatric Disease Subtyping. | Miranda L et al. | — | 2021 | → |
| Three models for the regulation of polygenic scores in reproduction. | Munday S et al. | — | 2021 | → |
| Translating polygenic risk scores for clinical use by estimating the confidence bounds of risk prediction. | Sun J et al. | — | 2021 | → |
| Validity and Prognostic Value of a Polygenic Risk Score for Parkinson's Disease. | Koch S et al. | — | 2021 | → |
| Assessing COVID-19 susceptibility through analysis of the genetic and epigenetic diversity of ACE2-mediated SARS-CoV-2 entry. | Ragia G et al. | — | 2020 | → |
| Four Actionable Bottlenecks and Potential Solutions to Translating Psychiatric Genetics Research: An Expert Review. | Bourdon JL et al. | — | 2020 | → |
| Modulation of Stem Cells as Therapeutics for Severe Mental Disorders and Cognitive Impairments. | Zhang Y et al. | — | 2020 | → |
| Polygenic risk scores and their potential clinical use in psychiatry: are we there yet? | Fries GR | — | 2020 | → |
| The emerging field of polygenic risk scores and perspective for use in clinical care. | Yanes T et al. | — | 2020 | → |
| Using common genetic variation to examine phenotypic expression and risk prediction in 22q11.2 deletion syndrome. | Davies RW et al. | — | 2020 | → |
| Development of Alcohol Use Disorder as a Function of Age, Severity, and Comorbidity with Externalizing and Internalizing Disorders in a Young Adult Cohort. | Nurnberger JI et al. | — | 2019 | → |